Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT06454409 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

20

Enrollment

OTHER

Sponsor class

Stopped resources

Conditions

Myelodysplastic Syndrome/Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
Recurrent Myelodysplastic Syndrome
Refractory Acute Myeloid Leukemia
Refractory Myelodysplastic Syndrome

Interventions

DRUG: Azacitidine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Regorafenib
DRUG: Venetoclax

Sponsor

City of Hope Medical Center

Collaborators

[object Object]